Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
J. Zhang, Y. Zhang, J. Kang, S. Chen, Y. He, B. Han, M. Liu, L. Lu, L. Li, Z. Yi, L. Chen
Abstract
The presence of SARS-CoV-2 mutants, including the emerging variant B.1.1.7, has raised great concerns in terms of pathogenesis, transmission, and immune escape. Characterizing SARS-CoV-2 mutations, evolution, and effects on infectivity and pathogenicity is crucial to the design of antibody therapies and surveillance strategies. Here we analyzed 454,443 SARS-CoV-2 spike genes/proteins and 14,427 whole-genome sequences. We demonstrated that the early variant B.1.1.7 may not have evolved spontaneously in the United Kingdom or within human populations. Our extensive analyses suggested that Canidae, Mustelidae or Felidae, especially the Canidae family (for example, dog) could be a possible host of the direct progenitor of variant B.1.1.7. An alternative hypothesis is that the variant was simply yet to be sampled. Notably, the SARS-CoV-2 whole genome represents a large number of potential co-mutations with very strong statistical significances (p value<E- 44). In addition, we used an experimental SARS-CoV-2 reporter replicon system to introduce the dominant co-mutations NSP12_c14408t, 5UTR_c241t, and NSP3_c3037t into the viral genome, and to monitor the effect of the mutations on viral replication. Our experimental results demonstrated that the co-mutations significantly attenuated the viral replication. The study provides valuable clues for discovering the transmission chains of variant B.1.1.7 and understanding the evolutionary process of SARS-CoV-2.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants
Austin N. Spratt, Saathvik R. Kannan, … Kamal Singh·bioRxiv·Mar 24, 2021
- Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
J. C. Brown, D. H. Goldhill, … W. S. Barclay·bioRxiv·Feb 24, 2021
- Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
S. J. Dicken, M. J. Murray, … J. Grove·bioRxiv·Mar 22, 2021
- The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic.
M. Calcagnile, P. Forgez, … M. Alifano·bioRxiv·Jan 12, 2021
- Progressing adaptation of SARS-CoV-2 to humans
T. Konishi·bioRxiv·Dec 18, 2020
- The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
V. Hill, L. du Plessis, … A. Rambaut·bioRxiv·Mar 8, 2022